Accugenomics Inc:企業の製品パイプライン分析

◆英語タイトル:Accugenomics Inc - Product Pipeline Analysis, 2020 Update
◆商品コード:GDME377468PD
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD1,500 ⇒換算¥192,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥288,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Accugenomics Inc (Accugenomics) is a developer of oncology molecular diagnostics. The company develops and markets gene expression tests to diagnose and monitor cancer treatment. It offers gene expression tests including lung cancer risk test, standardized BCR-ABL molecular diagnostics test and lung cancer diagnostic test. Accugenomics’ product candidates comprises of LCDT-AGx-3 Gene lung cancer diagnostic tests that helps in improving diagnostic precision as an adjunct to morphological criteria; and LCCT-AGx-4 Gene lung cancer chemoresistance test to estimate the response of different lung cancers to cisplatin or irinotecan related treatments. The company operates through its development laboratory in Wilmington, North Carolina. Accugenomics is headquartered in Wilmington, North Carolina, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Accugenomics Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Accugenomics Inc Company Overview
Accugenomics Inc Company Snapshot
Accugenomics Inc Pipeline Products and Ongoing Clinical Trials Overview
Accugenomics Inc – Pipeline Analysis Overview
Accugenomics Inc – Key Facts
Accugenomics Inc – Major Products and Services
Accugenomics Inc Pipeline Products by Development Stage
Accugenomics Inc Ongoing Clinical Trials by Trial Status
Accugenomics Inc Pipeline Products Overview
AccuKit
AccuKit Product Overview
Lung Cancer Chemoresistance Test – 4 Gene
Lung Cancer Chemoresistance Test – 4 Gene Product Overview
Lung Cancer Diagnostic Test – 3 Gene
Lung Cancer Diagnostic Test – 3 Gene Product Overview
Lung Cancer Risk Test – 13 Gene
Lung Cancer Risk Test – 13 Gene Product Overview
Lung Cancer Risk Test – 15 Gene
Lung Cancer Risk Test – 15 Gene Product Overview
Lung Cancer Risk Test – 15 Gene Clinical Trial
Accugenomics Inc – Key Competitors
Accugenomics Inc – Key Employees
Accugenomics Inc – Locations And Subsidiaries
Head Office
Recent Developments
Accugenomics Inc, Recent Developments
May 21, 2019: Precision Therapeutics’ Helomics division selected by AccuGenomics as preferred lab partner for NIIMBL grant
Aug 15, 2017: AccuGenomics Provides an AccuKit to Qura Therapeutics as Part of a Research Collaboration Agreement
Aug 15, 2017: AccuGenomics Provides an AccuKit to Qura Therapeutics as Part of a Research Collaboration Agreement
Jul 08, 2016: AccuGenomics presents their molecular standardization technology at GTCbio Molecular Diagnostic Conference in Boston, MA.
Jan 29, 2016: Release of lung cancer risk test trial details and establishment of biospecimen repository
Dec 18, 2015: Progress in Efforts to Develop AccuKit for Monitoring of BCR-ABL Treatment
Jul 01, 2015: STARSEQ Demonstrates Measurement of Undetected Errors that Arise in Next Generation Sequencing
Jun 11, 2015: SNAQ BCR-ABL Pilot Study Results Presented at 20th Annual European Hematology Association Meeting
Sep 07, 2014: Preliminary SNAQ BCR-ABL Pilot results presented at the 16th Annual John Goldman Conference on Chronic Myeloid Leukemia
Jul 01, 2014: AccuGenomics awarded United States patent for a molecular test that predicts lung cancer risk
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Accugenomics Inc Pipeline Products and Ongoing Clinical Trials Overview
Accugenomics Inc Pipeline Products by Equipment Type
Accugenomics Inc Pipeline Products by Indication
Accugenomics Inc Ongoing Clinical Trials by Trial Status
Accugenomics Inc, Key Facts
Accugenomics Inc, Major Products and Services
Accugenomics Inc Number of Pipeline Products by Development Stage
Accugenomics Inc Pipeline Products Summary by Development Stage
Accugenomics Inc Ongoing Clinical Trials by Trial Status
Accugenomics Inc Ongoing Clinical Trials Summary
AccuKit - Product Status
AccuKit - Product Description
Lung Cancer Chemoresistance Test - 4 Gene - Product Status
Lung Cancer Chemoresistance Test - 4 Gene - Product Description
Lung Cancer Diagnostic Test - 3 Gene - Product Status
Lung Cancer Diagnostic Test - 3 Gene - Product Description
Lung Cancer Risk Test - 13 Gene - Product Status
Lung Cancer Risk Test - 13 Gene - Product Description
Lung Cancer Risk Test - 15 Gene - Product Status
Lung Cancer Risk Test - 15 Gene - Product Description
Lung Cancer Risk Test - 15 Gene - Validation of a Multi-gene Test for Lung Cancer Risk
Accugenomics Inc, Key Employees
Glossary

★海外企業調査レポート[Accugenomics Inc:企業の製品パイプライン分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Lidds AB (LIDDS):企業の財務・戦略的SWOT分析
    Summary Lidds AB (Lidds) is a developer of pharmaceutical products for the treatment of cancer and other diseases. The company offers Liproca Depot, an injectable product used for the treatment of prostate cancer. Its Liproca is a bioresorbable, biocompatible and locally injectable modified release …
  • TESARO Inc (TSRO):製薬・医療:M&Aディール及び事業提携情報
    Summary TESARO Inc (TESARO) is an oncology-focused biopharmaceutical company that focuses on developing in-licensed, oncology-related product candidates and discovery of new candidates. It develops products using different approaches, comprising small molecules and immuno-oncology antibodies. The co …
  • Vitruvian Exploration II LLC:石油・ガス:M&Aディール及び事業提携情報
    Summary Vitruvian Exploration II LLC (Vitruvian Exploration II) is an oil and gas company that provides exploration and development of oil properties. The company provides exploration of onshore North American unconventional oil and gas resource plays. Its VEX II Woodford Apollo project has various …
  • Zhejiang Jihua Group Co Ltd (603980):企業の戦略的SWOT分析
    Zhejiang Jihua Group Co Ltd (603980) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • Medrobotics Corp:企業の製品パイプライン分析2018
    Summary Medrobotics Corp (Medrobotics), formerly Cardioborobotics Inc, is a medical device company that manufactures and markets flexible robot platforms. The company provides Flex robotic system, a robot-assisted surgical platform that offers physicians with single-site access while operating in ha …
  • Oakdale Electric Cooperative:発電所・企業SWOT分析
    Oakdale Electric Cooperative – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Valmet Corp (VALMT):企業の財務・戦略的SWOT分析
    Valmet Corp (VALMT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Cardiva Medical Inc:企業の戦略的SWOT分析
    Cardiva Medical Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Valeant Canada LP-製薬・医療分野:企業M&A・提携分析
    Summary Valeant Canada LP (Valeant Canada), a subsidiary of Valeant Pharmaceuticals International Inc, is a pharmaceutical company that manufactures, markets and distributes pharmaceutical products. The company offers its products in various therapeutic areas, including pain management, neurology, c …
  • Net One Systems Co Ltd (7518):企業の財務・戦略的SWOT分析
    Net One Systems Co Ltd (7518) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Italiaonline S.p.A. (IOL):企業の財務・戦略的SWOT分析
    Italiaonline S.p.A. (IOL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • TISCO Financial Group PCL:企業の戦略・SWOT・財務分析
    TISCO Financial Group PCL - Strategy, SWOT and Corporate Finance Report Summary TISCO Financial Group PCL - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Boone Electric Cooperative:企業の発電所・SWOT分析2018
    Boone Electric Cooperative - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key em …
  • Stantec Inc (STN):電力:M&Aディール及び事業提携情報
    Summary Stantec Inc. (Stantec) is a construction and consulting services company. The company offers architectural, engineering, and environmental services. Its service portfolio includes architecture and interior design, building engineering, community design services, geomatics, geotechnical engin …
  • Zynerba Pharmaceuticals Inc (ZYNE):製薬・医療:M&Aディール及び事業提携情報
    Summary Zynerba Pharmaceuticals Inc (Zynerba Pharmaceuticals), formerly AllTranz Inc, is a developer of next-generation synthetic cannabinoid therapeutics. The company provides pipeline product candidates such as ZYN002 and ZYN001. Its ZYN002 is a synthetic CBD, a non-psychoactive cannabinoid, formu …
  • Cancer Research UK-製薬・医療分野:企業M&A・提携分析
    Summary Cancer Research UK (CRUK) is a research institution which offers clinical research services to treat cancer. The institute offers research services for womb cancer, lung cancer, bladder cancer, bone cancer, bowel cancer, brain tumours, breast cancer, carcinoid, cervical cancer, children's ca …
  • India Glycols Ltd (INDIAGLYCO):企業の財務・戦略的SWOT分析
    India Glycols Ltd (INDIAGLYCO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Amcor Ltd:企業のM&A・事業提携・投資動向
    Amcor Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Amcor Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Population Genetics Technologies Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Population Genetics Technologies Ltd (Population Genetics), a subsidiary of Agilent Technologies Inc is a biotechnology company. The company commercialize nucleic acid biochemistry tools and approaches. Its intellectual property assets include method for normalizing a nucleic acid sample, me …
  • Sanyo Electric Co Ltd:企業のM&A・事業提携・投資動向
    Sanyo Electric Co Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Sanyo Electric Co Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆